ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0120

Incidence and Prevalence of Systemic Lupus Erythematosus in Urban China, 2013-2017: A Nationwide Population-based Study

Mucong Li1, Chaiquan Li2, Mengzhuo Cao3, Ke Lu2, Chanyuan Wu3, Jiuliang zhao1, Qian Wang4, Xinping Tian1, Xun Tang2, Mengtao Li1, xiaofeng Zeng4 and Pei Gao2, 1Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China, 2Peking University, Beijing, China, 3Peking Union Medical College Hospital, Beijing, China, 4Department of Rheumatology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China

Meeting: ACR Convergence 2023

Keywords: Economics, Epidemiology, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 12, 2023

Title: (0117–0144) Epidemiology & Public Health Poster I

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Systemic lupus erythematosus (SLE) is becoming a public health concern because of increasing disease and economic burdens. Epidemiological information on SLE, especially its incidence rate, was limited in developing countries. We aimed to investigate the incidence, prevalence, and cost burdens of SLE in urban China.

Methods: We conducted a nationwide population-based cohort study using the databases of Urban Employee Basic Medical Insurance and Urban Resident Basic Medical Insurance between 2013 and 2017, covering 23 provinces in China. Incidence and prevalence rates were age- and gender-standardized to China 2010 national census data. Average annual costs and hospital visit times were also calculated.

Results: Total 132,258 patients with SLE were identified during the study period. The mean age was 43.03 (SD, 15.29) years. Overall 81.33% of patients were women. The standardized incidence of SLE in China in 2017 was 14.09 (95%CI, 11.95-16.41) per 100,000 person-years (Figure 1). Women had higher incidence than men (26.41 vs 5.92 per 100,000 person-years). The standardized prevalence in 2017 were 47.61 (95%CI, 41.77-53.83), 94.16 (80.67-108.69), and 17.86 (13.84-22.38) per 100,000 people in overall, female, and male patients (Figure 2). The average annual rates of increase in prevalence were 21.50%, 19.72%, and 25.67% from 2013 to 2017 in overall, female, and male patients. The age-specific incidence peaked at 30-49 years old in women and at 40-59 years old in men. SLE incident and prevalent cases were most common in north-western and less in south and east China (Figure 3). Additionally, the average estimated annual cost per-capita was US$1,599.34 in SLE patients. Costs of adolescent and young adult patients were the highest among age groups.

Conclusion: SLE population in China is rapidly expanding. Younger age at onset, especially in women, has placed considerable burdens in China. The distinct signatures of different incidence rates with respect to geographic variations were consistent with regions’ exposure to ultraviolet radiation in China.

Supporting image 1

Incidence of SLE in urban China in 2017

Supporting image 2

Standardized prevalence of SLE in urban China from 2013 to 2017

Supporting image 3

Standardized incidence and prevalence rates of SLE by regions in China in 2017


Disclosures: M. Li: None; C. Li: None; M. Cao: None; K. Lu: None; C. Wu: None; J. zhao: None; Q. Wang: None; X. Tian: None; X. Tang: None; M. Li: None; x. Zeng: None; P. Gao: None.

To cite this abstract in AMA style:

Li M, Li C, Cao M, Lu K, Wu C, zhao J, Wang Q, Tian X, Tang X, Li M, Zeng x, Gao P. Incidence and Prevalence of Systemic Lupus Erythematosus in Urban China, 2013-2017: A Nationwide Population-based Study [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/incidence-and-prevalence-of-systemic-lupus-erythematosus-in-urban-china-2013-2017-a-nationwide-population-based-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/incidence-and-prevalence-of-systemic-lupus-erythematosus-in-urban-china-2013-2017-a-nationwide-population-based-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology